Executive SummaryAs anticipated, Robert Abrams, 61, named to newly created post of VP-special projects for the prescription drug claims processing unit of McKesson. Abrams was reported to be coming to PCS in December when the company tapped California Pharmacists Association Exec VP Robert Johnson as president ("The Pink Sheet" Dec. 18, T&G-2). Johnson has now been named chairman and CEO of PCS.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.